Pacira Divesting Iovera° Unit to Zimmer Biomet

Pacira BioSciences (PCRX) is divesting its iovera° business to Zimmer Biomet (ZBH) in an up to $140M deal. iovera° is "an innovative, FDA-cleared, drug-free medical device that relieves pain via cryoneurolysisâa process whereby focused cold therapy is applied to a targeted...</

Pacira BioSciences (PCRX) is divesting its iovera° business to Zimmer Biomet (ZBH) in an up to $140M deal. iovera° is “an innovative, FDA-cleared, drug-free medical device that relieves pain via cryoneurolysisâa process whereby focused cold therapy is applied to a targeted…

wsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser

Leave a Reply

Your email address will not be published. Required fields are marked *